SG144736A1 - Synthesis of temozolomide and analogs - Google Patents

Synthesis of temozolomide and analogs

Info

Publication number
SG144736A1
SG144736A1 SG200504445-8A SG2005044458A SG144736A1 SG 144736 A1 SG144736 A1 SG 144736A1 SG 2005044458 A SG2005044458 A SG 2005044458A SG 144736 A1 SG144736 A1 SG 144736A1
Authority
SG
Singapore
Prior art keywords
temozolomide
analogs
synthesis
relates
novel process
Prior art date
Application number
SG200504445-8A
Other languages
English (en)
Inventor
Shen-Chun Kuo
Janet L Mas
Donald Hou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of SG144736A1 publication Critical patent/SG144736A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/28—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG200504445-8A 2001-01-18 2002-01-16 Synthesis of temozolomide and analogs SG144736A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26246501P 2001-01-18 2001-01-18

Publications (1)

Publication Number Publication Date
SG144736A1 true SG144736A1 (en) 2008-08-28

Family

ID=22997631

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200504445-8A SG144736A1 (en) 2001-01-18 2002-01-16 Synthesis of temozolomide and analogs

Country Status (9)

Country Link
US (4) US7087751B2 (ja)
EP (1) EP1353924A1 (ja)
JP (2) JP4358510B2 (ja)
CN (4) CN101220033A (ja)
AR (1) AR035419A1 (ja)
CA (1) CA2434308C (ja)
MX (1) MXPA03006403A (ja)
SG (1) SG144736A1 (ja)
WO (1) WO2002057269A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063757A2 (en) 2003-12-30 2005-07-14 Chemagis Ltd. Novel crystalline forms of temozolomide
DE102006007309B4 (de) * 2005-02-17 2012-11-29 Chemagis Ltd. Verbessertes Verfahren zur Herstellung von Temozolomid
CN1300143C (zh) * 2005-04-08 2007-02-14 江苏天士力帝益药业有限公司 替莫唑胺的精制方法
US20060222792A1 (en) * 2006-04-21 2006-10-05 Chemagis Ltd. Temozolomide storage system
ZA200901970B (en) 2006-09-29 2010-01-27 Cipla Ltd An improved process for the preparation of temozolomide and analogs
PE20091101A1 (es) 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
EP2151442A3 (en) * 2008-08-07 2011-04-06 Chemi SPA Process for preparing temozolomide
WO2010091198A1 (en) 2009-02-06 2010-08-12 University Of Southern California Therapeutic compositions comprising monoterpenes
WO2010140168A1 (en) * 2009-06-03 2010-12-09 Ind-Swift Laboratories Limited Improved process for preparing temozolomide
PL2445915T3 (pl) 2009-06-23 2016-10-31 Związki 3-podstawionego-8-podstawionego-3H imidazo[5,1-d][1,2,3,5 tetrazyn]-4-onu i ich zastosowanie
WO2011036676A2 (en) 2009-09-23 2011-03-31 Ashwini Nangia Stable cocrystals of temozolomide
EP2542553A1 (en) 2010-03-01 2013-01-09 Pharminox Ltd Methods and intermediates for the synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazines
CN102070639B (zh) * 2010-12-21 2012-10-10 中南大学 一种替莫唑胺的合成方法
CN102659789B (zh) * 2011-04-27 2014-10-15 四川科瑞德凯华制药有限公司 一锅法制备替莫唑胺的方法及替莫唑胺的精制方法
SI3532059T1 (sl) 2016-10-27 2022-06-30 Celgene Quanticel Research, Inc. Kombinacijska terapija z bromodomeno in ekstra terminalnim inhibitorskim proteinom
WO2020194168A1 (en) * 2019-03-25 2020-10-01 Shivalik Rasayan Limited Process for preparing highly pure temozolomide
CN111233871B (zh) * 2020-03-17 2021-11-12 江苏美迪克化学品有限公司 一种替莫唑胺的制备方法
US11597731B2 (en) 2021-07-17 2023-03-07 Shivalik Rasayan Limited Process for preparing highly pure temozolomide
JP2023043987A (ja) 2021-09-17 2023-03-30 キオクシア株式会社 基板処理装置及び基板処理方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941768A (en) 1968-05-30 1976-03-02 Ciba-Geigy Ag One step diazotization coupling process
JPS5318521A (en) 1976-08-04 1978-02-20 Nippon Kayaku Co Ltd Preparation of 3,5-dichloronitrogenzene
JPS5334745A (en) 1976-09-11 1978-03-31 Kyowa Hakko Kogyo Co Ltd Preparation of 2-(4-alkylphenyl)propionic acids
JPS582229B2 (ja) 1977-04-11 1983-01-14 住友化学工業株式会社 グリシンエステルの製法
JPS5920665B2 (ja) 1977-07-06 1984-05-15 住友化学工業株式会社 フエニルヒドラジンの精製方法
JPS5441830A (en) 1977-09-07 1979-04-03 Seitetsu Kagaku Co Ltd Production of p-hydroxybenzaldehyde
JPS5459283A (en) 1977-10-18 1979-05-12 Ishihara Sangyo Kaisha Ltd Preparation of 2,3,5-trichloropyridine
JPS609703B2 (ja) 1977-11-14 1985-03-12 田辺製薬株式会社 光学活性ベンジルアルコール誘導体の製法
JPS609702B2 (ja) 1977-11-14 1985-03-12 田辺製薬株式会社 光学活性ベンジルアルコール誘導体の製法
JPS6058221B2 (ja) 1977-11-15 1985-12-19 日産化学工業株式会社 置換ジフエニルアミン及びその製造方法
JPS54102127A (en) 1978-01-27 1979-08-11 Mitsubishi Electric Corp Recording method for card surface
JPS54130598A (en) 1978-03-31 1979-10-09 Mitsui Toatsu Chem Inc Preparation of 1,2-dihydro-3h-pyrrolo3,2-eindole derivative
JPS5821937B2 (ja) 1978-07-05 1983-05-04 住友化学工業株式会社 アゾレ−キ顔料の製造法
JPS5517349A (en) 1978-07-24 1980-02-06 Rikagaku Kenkyusho Production of diterpene derivative
US5260291A (en) 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
EP0113570B1 (en) * 1982-12-20 1987-02-25 Merck & Co. Inc. 5-(amino or substituted amino) imidazoles
GB8616125D0 (en) 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
FI89906C (fi) 1988-05-17 1993-12-10 Lonza Ag Foerfarande foer framstaellning av aminocyanacetamid
US5942247A (en) 1996-07-31 1999-08-24 Schering Corporation Method for treating pediatric high grade astrocytoma including brain stem glioma
US5824346A (en) 1996-08-22 1998-10-20 Schering Corporation Combination therapy for advanced cancer
US5939098A (en) 1996-09-19 1999-08-17 Schering Corporation Cancer treatment with temozolomide
US6096757A (en) 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
US6251886B1 (en) 1998-12-07 2001-06-26 Schering Corporation Methods of using temozolomide in the treatment of cancers
US6346524B1 (en) 1999-03-30 2002-02-12 Schering Corporation Cancer treatment with temozolomide
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
JP4105821B2 (ja) 1999-05-17 2008-06-25 富士フイルム株式会社 ジアゾ化合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
A NEW ROUTE TO THE ANTITUMOR DRUG TEMOZOLOMIDE, BUT NOT THIOTEMOZOLOMIDE *
ANTITUMOR IMIDAZOTETRAZINES. 35. NEW SYNTHETIC ROUTES TO THE ANTITUMOR DRUG TEMOZOLOMIDE *
ANTITUMOR IMIDAZOTETRAZINES. PART 33 *
ANTITUMOR IMIDAZOTETRAZINES. PART 36 ..... *

Also Published As

Publication number Publication date
AR035419A1 (es) 2004-05-26
US20060229456A1 (en) 2006-10-12
US7087751B2 (en) 2006-08-08
MXPA03006403A (es) 2003-10-15
US20050131227A1 (en) 2005-06-16
CN101195589A (zh) 2008-06-11
US7446209B2 (en) 2008-11-04
CN1269819C (zh) 2006-08-16
CN100372852C (zh) 2008-03-05
CN1487941A (zh) 2004-04-07
JP2004518673A (ja) 2004-06-24
EP1353924A1 (en) 2003-10-22
CA2434308C (en) 2010-09-21
CA2434308A1 (en) 2002-07-25
US20020095036A1 (en) 2002-07-18
US20090023919A1 (en) 2009-01-22
WO2002057269A1 (en) 2002-07-25
US7737284B2 (en) 2010-06-15
JP4358510B2 (ja) 2009-11-04
CN1800184A (zh) 2006-07-12
JP2009024025A (ja) 2009-02-05
CN101220033A (zh) 2008-07-16

Similar Documents

Publication Publication Date Title
SG144736A1 (en) Synthesis of temozolomide and analogs
MXPA04008613A (es) N-aminoacetil-pirrolidina-2-carbonitrilos y su uso como inhibidores de ddp-iv.
SG143062A1 (en) Synthesis of temozolomide and analogs
YU82403A (sh) Jedinjenja spiropirazola
HK1080088A1 (zh) 製備c-7取代的5-雄甾烯的方法
IL175253A0 (en) A process for preparing pyrrole derivatives
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
SI1509517T1 (sl) Nova sinteza irbesartana
MXPA04000357A (es) COMPUESTO QUE CONTIENE AMIDA Y TIENE UNA MEJOR SOLUBILIDAD, Y MeTODO PARA MEJORAR LA SOLUBILIDAD DE UN COMPUESTO QUE CONTIENE AMIDA.
AU2003255483A1 (en) Process for the conversion of polysulfanes
MXPA04000847A (es) Procedimiento para la obtencion de beraprost y sus sales.
IL159718A0 (en) Synthesis of intermediates for preparation of stating derivatives
GB0327323D0 (en) Novel pharmaceuticals
WO2004048380A8 (en) Process for the synthesis of ganciclovir
MXPA03008946A (es) Metodos para sintetizar compuestos que contienen fenol.
SG146645A1 (en) Process for the synthesis of 6-amino-4-(3-chloro-4fluoro-phenylamino)-7- ethoxy-quinoline-3-carbonitrile
HK1037617A1 (en) Process for the preparation of imidazodiazepine intermediates
GB9909229D0 (en) Enantiomers of mercapto lactones and processes for their synthesis
GB0320738D0 (en) Novel process
HUP0400767A2 (hu) Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
MXPA05003881A (es) Preparacion de compuestos triazospiro.
MXPA04003085A (es) Proceso estereoespecifico para sintesis de derivados de 2-il cromano.
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine